News Daily News Survey Calls Out Implicit Bias in Peripheral Vascular Care L.A. McKeown February 28, 2025
News Daily News New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients L.A. McKeown August 19, 2024
News Daily News Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients L.A. McKeown July 24, 2024
News Conference News SCAI 2024 No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis L.A. McKeown May 10, 2024
News Daily News JACC Statement Focuses on PAD Disparities, Gaps in Care L.A. McKeown December 04, 2023
News Conference News TCT 2023 LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI L.A. McKeown October 25, 2023
News Daily News Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA L.A. McKeown July 11, 2023
News Conference News SCAI 2023 CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI L.A. McKeown May 25, 2023
News Conference News SCAI 2023 Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI L.A. McKeown May 24, 2023
News Daily News REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD L.A. McKeown January 24, 2023
News Conference News AHA 2022 Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI L.A. McKeown November 07, 2022
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Daily News Worse Complications After PVI in Women Highlight Research Gaps L.A. McKeown August 16, 2022
News Daily News Statins Underprescribed in PAD Before and After Interventions L.A. McKeown December 03, 2021
News Daily News FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon L.A. McKeown February 18, 2021
News Conference News AHA 2020 AFFIRM-AHF: IV Iron Supplementation Linked to Fewer Repeat Hospitalizations for HF L.A. McKeown November 13, 2020
News Conference News ACC 2020 New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy L.A. McKeown April 02, 2020